|
DE1266763B
(de)
*
|
1965-07-27 |
1968-04-25 |
Kalle Ag |
Verfahren zur Herstellung von in 3-Stellung substituierten Indol- und Indazolderivaten
|
|
EP0924209B1
(en)
|
1997-12-19 |
2003-05-02 |
Eli Lilly And Company |
Hypoglycemic imidazoline compounds
|
|
GB9816263D0
(en)
*
|
1998-07-24 |
1998-09-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9905010D0
(en)
|
1999-03-04 |
1999-04-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2001017965A2
(en)
|
1999-09-07 |
2001-03-15 |
Syngenta Participations Ag |
Cyanopiperidines as pesticides
|
|
FR2801585B1
(fr)
|
1999-11-25 |
2002-02-15 |
Fournier Ind & Sante |
Nouveaux antagonistes des recepteurs de l'ii-8
|
|
GB0003397D0
(en)
|
2000-02-14 |
2000-04-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2002028831A1
(en)
|
2000-10-02 |
2002-04-11 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
FR2824826B1
(fr)
|
2001-05-17 |
2003-11-07 |
Fournier Lab Sa |
Nouveaux derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8
|
|
FR2824827B1
(fr)
|
2001-05-17 |
2004-02-13 |
Fournier Lab Sa |
Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8
|
|
KR20050044450A
(ko)
|
2001-11-14 |
2005-05-12 |
테바 파마슈티컬 인더스트리즈 리미티드 |
로사르탄 칼륨의 무정형 및 결정형 형태 및 이의 제조 방법
|
|
WO2003104180A1
(en)
|
2002-06-05 |
2003-12-18 |
Natco Pharma Limited |
Process for the preparation of 4-(4-fluorobenzoyl) butyric acid
|
|
WO2004058717A1
(en)
|
2002-12-20 |
2004-07-15 |
X-Ceptor Therapeutics, Inc. |
Isoquinolinone derivatives and their use as therapeutic agents
|
|
AU2004268919A1
(en)
|
2003-09-03 |
2005-03-10 |
Galapagos Nv |
Novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-HT2A receptor-related disorders
|
|
WO2005092854A1
(en)
|
2004-03-03 |
2005-10-06 |
Eli Lilly And Company |
Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
|
|
WO2007061763A2
(en)
|
2005-11-22 |
2007-05-31 |
Merck & Co., Inc. |
Indole orexin receptor antagonists
|
|
PT2118074E
(pt)
|
2007-02-01 |
2014-03-20 |
Resverlogix Corp |
Compostos para a prevenção e tratamento de doenças cardiovasculares
|
|
EP2178870B1
(en)
|
2007-08-17 |
2018-09-19 |
LG Chem, Ltd. |
Indole and indazole compounds as an inhibitor of cellular necrosis
|
|
AU2009263037B2
(en)
*
|
2008-06-26 |
2011-10-06 |
Amgen Inc. |
Alkynyl alcohols as kinase inhibitors
|
|
KR101605061B1
(ko)
|
2009-05-29 |
2016-03-21 |
라퀄리아 파마 인코포레이티드 |
칼슘 또는 나트륨 채널 차단제로서의 아릴 치환된 카복사미드 유도체
|
|
WO2012025155A1
(en)
|
2010-08-26 |
2012-03-01 |
Novartis Ag |
Hydroxamate-based inhibitors of deacetylases
|
|
US10130632B2
(en)
|
2012-11-27 |
2018-11-20 |
Beth Israel Deaconess Medical Center, Inc. |
Methods for treating renal disease
|
|
US9850203B2
(en)
|
2013-09-26 |
2017-12-26 |
Pharmakea, Inc. |
Autotaxin inhibitor compounds
|
|
ES2895490T3
(es)
|
2014-03-27 |
2022-02-21 |
Acad Medisch Ct |
Iminoazúcares N-(5-(bifen-4-ilmetiloxi)pentil)-sustituidos como inhibidores de glucosilceramida sintasa
|
|
WO2016029310A1
(en)
|
2014-08-27 |
2016-03-03 |
The Governing Council Of The University Of Toronto |
Cannabinoid type 1 receptor modulators
|
|
BR112017007178A2
(pt)
|
2014-10-08 |
2017-12-19 |
Ass Francaise Contre Les Myopathies |
compostos de aminopiridina úteis como inibidores de prenilação de proteína
|
|
HRP20210472T1
(hr)
|
2015-08-27 |
2021-05-14 |
Pfizer Inc. |
Biciklički kondenzirani heteroarilni ili arilni spojevi kao modulatori irak4
|
|
CN106008477B
(zh)
*
|
2016-06-02 |
2019-02-26 |
苏州大学 |
3-(2-芳基-1h-吲哚-3-基)-4-羟基呋喃-2(5h)-酮及其合成方法
|
|
EP3787669A4
(en)
|
2018-04-30 |
2022-03-30 |
The Trustees of Indiana University |
COMPOUNDS FOR MODULATION OF LEVELS OF DDAH AND ADMA AND METHODS OF USE THEM TO TREAT DISEASES
|
|
CN118127019A
(zh)
|
2018-05-22 |
2024-06-04 |
Ionis制药公司 |
Apol1表达的调节剂
|
|
LT3897833T
(lt)
*
|
2018-12-17 |
2026-04-27 |
Vertex Pharmaceuticals Incorporated |
Apol1 inhibitoriai ir jų panaudojimo būdai
|
|
EP4097083A1
(en)
*
|
2020-01-29 |
2022-12-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of apol1 and methods of using same
|
|
US20210246121A1
(en)
|
2020-02-04 |
2021-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of apol1 inhibitor and methods of using same
|
|
EP4114385A1
(en)
|
2020-03-06 |
2023-01-11 |
Vertex Pharmaceuticals Incorporated |
Methods of treating apol-1 dependent focal segmental glomerulosclerosis
|
|
EP4146633A4
(en)
|
2020-05-07 |
2024-09-25 |
Rambam Med-Tech Ltd. |
COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH APOL1
|
|
CN115867543A
(zh)
|
2020-06-12 |
2023-03-28 |
弗特克斯药品有限公司 |
Apol1抑制剂的固体形式及其使用方法
|
|
US20230014907A1
(en)
|
2020-06-12 |
2023-01-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of apol1 and methods of using same
|
|
JP2023530271A
(ja)
|
2020-06-12 |
2023-07-14 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Apol1の阻害剤及びこれを使用する方法
|
|
BR112023003423A2
(pt)
|
2020-08-26 |
2023-03-21 |
Vertex Pharma |
Inibidores de apol1 e métodos de uso destes
|
|
KR20240051990A
(ko)
|
2021-08-26 |
2024-04-22 |
버텍스 파마슈티칼스 인코포레이티드 |
스피로트리시클릭 apol1 억제제의 고형분 형태 및 이의 사용 방법
|
|
US12612379B2
(en)
|
2021-11-30 |
2026-04-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of APOL1 and methods of using same
|
|
AU2022401847A1
(en)
|
2021-11-30 |
2024-06-06 |
Vertex Pharmaceuticals Incorporated |
Spirocyclic inhibitors of apol1 and methods of using same
|
|
EP4476228A1
(en)
|
2022-02-08 |
2024-12-18 |
Vertex Pharmaceuticals Incorporated |
4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using same
|
|
CN119343353A
(zh)
|
2022-02-08 |
2025-01-21 |
弗特克斯药品有限公司 |
作为APOL1抑制剂的2-甲基-4',5'-二氢螺[哌啶-4,7'-噻吩并[2,3-c]吡喃]衍生物和其使用方法
|
|
WO2023154314A1
(en)
|
2022-02-08 |
2023-08-17 |
Vertex Pharmaceuticals Incorporated |
Spiro piperidine derivatives as inhibitors of apol1 and methods of using same
|
|
EP4476199A1
(en)
|
2022-02-08 |
2024-12-18 |
Vertex Pharmaceuticals Incorporated |
2-methyl-4-phenylpiperidin-4-ol derivatives as inhibitors of apol1 and methods of using same
|